Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 11 - 20 of about 172   

Articles published

GSK 1,515.86 -3.14 (-0.21%)
price chart
GlaxoSmithKline plc (GSK): Time For A Financial Health Check
A market capitalization of $95.56B puts GlaxoSmithKline plc (NYSE:GSK) in the basket of stocks categorized as large-caps. These stocks draw significant attention from the investing community due to its size and liquidity.
Buy the stocks that will change your money multiplying rate: GlaxoSmithKline ...  The News Journal
GlaxoSmithKline plc 17.6% Potential Upside Indicated by Bryan Garnier  Newburgh Gazette
GlaxoSmithKline plc 6.2% Potential Upside Indicated by Deutsche Bank
GlaxoSmithKline plc using EPIC/TICKER code (LON:GSK) had its stock rating noted as 'Reiterates' with the recommendation being set at 'HOLD' today by analysts at Deutsche Bank.
GlaxoSmithKline plc's (GSK) “Hold” Rating Reiterated at Deutsche Bank AG  The Ledger Gazette
Equity Research Analysts at Deutsche Bank Reiterate their “Hold” rating for ...
Glaxosmithkline Plc (GSK) Moves -0.32%
Shares of Glaxosmithkline Plc (GSK) have seen the needle move -0.32% or -0.13 in the most recent session. The NYSE listed company saw a recent bid of $40.73 on 3747823 volume.
Volume: A Tool to Project Future Performance: GlaxoSmithKline plc (NYSE: GSK)
On Monday, Shares of GlaxoSmithKline plc (NYSE: GSK) expressed a change of -0.15% and is currently trading at $40.95. The stock exchanged hands with 1,295,644 numbers of shares compared to its average daily volume of 3.11M shares.
4 share prices I'm watching this week: Next plc, GlaxoSmithKline plc, easyJet ...
GlaxoSmithKline has been a disappointment in 2017 in my opinion. The healthcare company's share price has fallen 2% since the start of the year.
Research Analysts at Peel Hunt Kept their Buy rating for Avon Rubber PLC ...  San Times
Were Analysts Bullish John Wood Group PLC (LON:WG) This Week?  Newburgh Gazette
Why I'd buy this biotechnology star alongside GlaxoSmithKline plc
There's still a youthful growth-investor hidden within me, and I do get tempted by potential future stars from time to time. Right now, I'm looking at the prospects for MaxCyte (LSE: MXCT), which released first-half results Tuesday.
Pre-Market Most Active for Oct 17, 2017 : GSK, IPXL, NFLX, MU, MS, FCX, SNCR ...
GlaxoSmithKline PLC ( GSK ) is -0.0376 at $40.82, with 792,000 shares traded. GSK's current last sale is 86.86% of the target price of $47.
Share Activity Lifted for Glaxosmithkline Plc (GSK) in Session
Glaxosmithkline Plc (GSK) shares are moving today on volatility -0.54% or $-0.22 from the open. The NYSE listed company saw a recent bid of 40.79 and 3285561 shares have traded hands in the session.
Analysts Pounding the Pavement on GlaxoSmithKline PLC (NYSE:GSK)
Most recently GlaxoSmithKline PLC (NYSE:GSK) posted quarterly earnings of $0.7 which compared to the sell-side estimates of 0.83.
Short-Term Signal Watch on Glaxosmithkline Plc (GSK)
Checking in on the short-term signals on Glaxosmithkline Plc (GSK), we note that the current 7-day average directional indicator is Buy.